撒哈拉以南非洲淋球菌感染流行病学模式系统综述与荟萃分析
随机效应荟萃分析显示一般人群泌尿生殖道淋球菌合并患病率为3.2%(95%CI:2.9—3.5),重点人群患病率更高,且患病率呈每年下降1%的长期趋势。
要点
- 一般人群泌尿生殖道淋球菌合并患病率为3.2%(95%CI:2.9—3.5),研究间异质性大。
- 女性性工作者泌尿生殖道患病率11.5%,MSM肛直肠感染8.3%,为重点人群。
- 有症状男性泌尿生殖道患病率高达51.5%,提示症状驱动检测的重要性。
核心结论
- 撒哈拉以南非洲淋球菌患病率仍显著偏高,但随时间呈下降趋势。
- 需加强监测、扩展预防与诊断策略,并持续监测淋球菌抗菌药物耐药性。
研究设计与样本
- 系统综述与荟萃分析,遵循PRISMA指南,检索Embase、PubMed、Scopus和Web of Science至2025年6月4日。
- 采用随机效应荟萃分析生成合并患病率估计,随机效应荟萃回归分析关联与异质性来源。
主要发现
- 一般人群泌尿生殖道合并患病率为3.2%(95%CI:2.9—3.5),研究间异质性大、预测区间宽。
- 女性性工作者泌尿生殖道患病率11.5%(95%CI:9.9—13.2),肛直肠感染2.0%(95%CI:0.4—4.5)。
- MSM泌尿生殖道患病率2.8%(95%CI:2.4—3.3),肛直肠8.3%(95%CI:5.8—11.0),口咽5.7%(95%CI:3.6—8.3)。
- 有症状男性泌尿生殖道患病率51.5%(95%CI:47.5—55.5),有症状女性9.0%(95%CI:7.7—10.4)。
- 发生不良妊娠或出生结局的女性泌尿生殖道患病率为8.6%(95%CI:5.3—12.6)。
关键数值与推荐
- 荟萃回归解释超过一半的患病率变异,显示患病率每年下降1%。
- 存在明显人群类型梯度与次区域差异,患病率随年龄增长而下降,但无性别差异。
临床怎么用
- 应针对女性性工作者、MSM及有症状人群等重点人群强化淋球菌筛查与诊断。
- 在产前保健中关注淋球菌感染,以减少不良妊娠与出生结局。
- 将抗菌药物耐药监测纳入淋病防控规划,支撑撒哈拉以南非洲的有效控制。
局限性
- 研究结果可能受各国、解剖部位和人群间数据可获得性差异的影响。
- 纳入研究之间存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Neisseria gonorrhoeae (NG) infection is a global health concern because of its morbidity and increasing antimicrobial resistance. Sub-Saharan Africa is believed to carry a disproportionately high burden of NG infection, but the epidemiology of NG infection in this region has not been comprehensively synthesized. This study systematically reviewed and analyzed NG prevalence in sub-Saharan Africa to characterize prevalence patterns and identify populations at risk. METHODS AND FINDINGS: A systematic review was conducted and reported following PRISMA guidelines. Embase, PubMed, Scopus, and Web of Science were searched from inception to June 4, 2025. Eligible studies reported NG prevalence in sub-Saharan Africa. Random-effects meta-analyses generated pooled prevalence estimates, and random-effects meta-regression analyses identified associations and sources of heterogeneity. Nine hundred fifty publications contributed 1,604 prevalence measures spanning 1964-2025. In the general population, pooled urogenital prevalence was 3.2% (95% confidence interval (CI): 2.9-3.5), with substantial between-study heterogeneity and a wide prediction interval, indicating considerable variation in prevalence across settings. Prevalence was high in key populations: among female sex workers, 11.5% (95% CI: 9.9-13.2) for urogenital and 2.0% (95% CI: 0.4-4.5) for anorectal infection; and among men who have sex with men, 2.8% (95% CI: 2.4-3.3) for urogenital, 8.3% (95% CI: 5.8-11.0) for anorectal, and 5.7% (95% CI: 3.6-8.3) for oropharyngeal infection. Symptomatic men exhibited high urogenital prevalence (51.5%; 95% CI: 47.5-55.5), and symptomatic women showed 9.0% (95% CI: 7.7-10.4). Among women with adverse pregnancy or birth outcomes, urogenital prevalence was 8.6% (95% CI: 5.3-12.6). Meta-regression analyses explained over half of the variability in prevalence, showing a long-term decline of 1% per year, a clear population type gradient, subregional differences, and decreasing prevalence with increasing age, but no variation by sex. These findings may be affected by variability in data availability across countries, anatomical sites, and population groups, as well as heterogeneity across included studies. CONCLUSIONS: NG prevalence remains markedly high in this region but has declined over time. These findings highlight the need for strengthened surveillance, expanded prevention and diagnostic strategies, and continued monitoring of gonococcal antimicrobial resistance to support effective control efforts in sub-Saharan Africa.
引用
- Osman A, Akram H, Alemrayat B, et al. Prevalence and epidemiological patterns of Neisseria gonorrhoeae infection in sub-Saharan Africa, 1964-2025: Systematic review, meta-analyses, and meta-regressions. PLoS Med. 2026. PMID: 42335017. doi:10.1371/journal.pmed.1004936
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。